ArticlePloS one2017

Rev-erb agonist improves adverse cardiac remodeling and survival in myocardial infarction through an anti-inflammatory mechanism.

Endin Nokik Stujanna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.